Forced enhancer-promoter rewiring to alter gene expression in animal models

Scott A. Peslak(Children's Hospital of Philadelphia), Gerd A. Blobel(Children's Hospital of Philadelphia), Wei Tong(Children's Hospital of Philadelphia), Francesca Ferrara(St. Jude Children's Research Hospital), Matthew M. Wielgosz(St. Jude Children's Research Hospital), Khaled Essawi(National Institutes of Health), Nathaniel S. Linde(National Institutes of Health), Aylin Bonifacino(National Institutes of Health), Selami Demirci(National Institutes of Health), Vemika Chandra(Children's Hospital of Philadelphia), Alexis Leonard(St. Jude Children's Research Hospital), Naoya Uchida(National Heart Lung and Blood Institute), Byoung Y. Ryu(CTI BioPharma (United States)), Paula Germino-Watnick(National Institutes of Health), Robert E. Throm(St. Jude Children's Research Hospital), Mitchell J. Weiss(St. Jude Children's Research Hospital), Rebecca Chu(National Institutes of Health), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Robert E. Donahue(National Institute of Diabetes and Digestive and Kidney Diseases), Jeremy Rupon(Pfizer (United States)), Malikiya Hinds(National Institutes of Health), Nicole Hamagami(Washington University in St. Louis), Anh‐Tuan Le(National Institutes of Health), Saurabh K. Bhardwaj(Children's Hospital of Philadelphia), Allen E. Krouse(National Institutes of Health), Jing Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), John F. Tisdale(National Heart Lung and Blood Institute)

Molecular Therapy — Nucleic Acids

January 31, 2023

Cited by 10

|Molecular Cell|2016|382

|Molecular and Cellular Biology|2004|352

|eLife|2020|347

|Nature Methods|2011|337

|Science|2023|321

Related Papers